“…One item (Q19 deal with physical symptoms after taking the medicines) showed cross‐loading in the domain of “daily care and social interaction needs” with factor loading 0.49 and “psychological needs” with factor loading 0.40. However, the authors unanimously agreed to retain the item Q19 in the domain of “daily care and social interaction needs” because renal recipients generally experienced symptom distress related to immunosuppressive drugs (Robledo et al, 2018; Wei et al, 2016). Studies have indicated that recipients may experience different side effects such as forgetfulness, fatigue, tremor (Wei et al, 2016), itchy skin, decreased eyesight, sleep disorder (Wei, 2017) and hair loss (Teng et al, 2015) because of immunosuppressive drug treatment.…”